Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress

    NEXT STORY
    Gluconite Reviews: Negative Side Effects or Real Ingredients That Work? 2021 Review
    PREV STORY
    Sorrento Receives US FDA Clearance to Proceed With Phase 1 Study for STI-2099 (Intranasal COVIDROPS) in Healthy Volunteers and Outpatient Treatment for Newly Diagnosed COVID-19 Positive Patients
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curetis to Report its Half-Year Results 2018 on August 14, 2018

    Curetis to Report its Half-Year Results 2018 on August 14, 2018 - Company will ...

    author_avatar
    NASDAQ Market News

    Palette Life Sciences Celebrates Twenty Years of Deflux Treatment for Vesicoureteral Reflux (VUR) in the United States

    author_avatar
    NASDAQ Market News

    To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors

    author_avatar
    NASDAQ Market News